These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11887165)

  • 1. Metabolic response to a C-glucose load in human immunodeficiency virus patients before and after antiprotease therapy.
    Korach M; Leclercq P; Péronnet F; Leverve X
    Metabolism; 2002 Mar; 51(3):307-13. PubMed ID: 11887165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hepatic and whole body glycogen metabolism in humans during repeated administrations of small loads of 13C glucose.
    Selz R; Theintz G; Tappy L; Schneiter P
    Diabetes Metab; 2003 Dec; 29(6):643-9. PubMed ID: 14707895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients.
    Pernerstorfer-Schoen H; Schindler K; Parschalk B; Schindl A; Thoeny-Lampert S; Wunderer K; Elmadfa I; Tschachler E; Jilma B
    AIDS; 1999 Dec; 13(17):2389-96. PubMed ID: 10597780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate utilization in boys during exercise with [13C]-glucose ingestion.
    Riddell MC; Bar-Or O; Schwarcz HP; Heigenhauser GJ
    Eur J Appl Physiol; 2000 Nov; 83(4 -5):441-8. PubMed ID: 11138587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
    AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate utilization in obese subjects after an oral load of 100 g naturally-labelled [13C] glucose.
    Ravussin E; Doerner A; Acheson KJ; Pahud P; Arnaud MJ; Jéquier E
    Br J Nutr; 1980 Mar; 43(2):281-8. PubMed ID: 6990967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
    Hammer SM; Vaida F; Bennett KK; Holohan MK; Sheiner L; Eron JJ; Wheat LJ; Mitsuyasu RT; Gulick RM; Valentine FT; Aberg JA; Rogers MD; Karol CN; Saah AJ; Lewis RH; Bessen LJ; Brosgart C; DeGruttola V; Mellors JW;
    JAMA; 2002 Jul; 288(2):169-80. PubMed ID: 12095381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.
    Duval X; Peytavin G; Albert I; Bénoliel S; Ecobichon JL; Brun-Vézinet F; Mentré F; Leport C; Vildé JL
    HIV Med; 2004 Jul; 5(4):307-13. PubMed ID: 15236622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
    Rudin C; Burri M; Shen Y; Rode R; Nadal D; ;
    Pediatr Infect Dis J; 2008 May; 27(5):431-7. PubMed ID: 18382386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.
    Tebas P; Yarasheski K; Henry K; Claxton S; Kane E; Bordenave B; Klebert M; Powderly WG
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):589-94. PubMed ID: 15242534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
    McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
    Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic control.
    Blass SC; Ellinger S; Vogel M; Ingiliz P; Spengler U; Stehle P; von Ruecker A; Rockstroh JK
    Eur J Med Res; 2008 May; 13(5):209-14. PubMed ID: 18559303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitor therapy improves protein catabolism in prepubertal children with HIV infection.
    Hardin DS; Ellis KJ; Rice J; Doyle ME
    J Pediatr Endocrinol Metab; 2004 Mar; 17(3):321-5. PubMed ID: 15112908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
    Meininger G; Hadigan C; Laposata M; Brown J; Rabe J; Louca J; Aliabadi N; Grinspoon S
    Metabolism; 2002 Feb; 51(2):260-6. PubMed ID: 11833059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children.
    Bitnun A; Sochett E; Dick PT; To T; Jefferies C; Babyn P; Forbes J; Read S; King SM
    J Clin Endocrinol Metab; 2005 Jan; 90(1):168-74. PubMed ID: 15483082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy.
    Hadigan C; Borgonha S; Rabe J; Young V; Grinspoon S
    Metabolism; 2002 Sep; 51(9):1143-7. PubMed ID: 12200758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of osmolality on availability of glucose ingested during prolonged exercise in humans.
    Jandrain BJ; Pirnay F; Lacroix M; Mosora F; Scheen AJ; Lefebvre PJ
    J Appl Physiol (1985); 1989 Jul; 67(1):76-82. PubMed ID: 2668258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nelfinavir: an update on its use in HIV infection.
    Bardsley-Elliot A; Plosker GL
    Drugs; 2000 Mar; 59(3):581-620. PubMed ID: 10776836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.